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November 2, 2016 
The 2016 World Food Prize was awarded in Oc-
tober to four scientists for their pioneering work 
on bio-fortification — a process of enhancing 
traditional foods with micronutrients, particu-
larly vitamins and minerals, through conven-
tional selective breeding or genetic engineering. 
Three of the laureates who work in African 
countries bred and championed the orange-
fleshed sweet potatoes1. Although not native to 
the African continent, the orange-fleshed sweet 
potato is enhanced with beta-carotene to boost 
vitamin A content and combat vitamin A defi-
ciency, a health challenge in many developing 
countries.  
Despite their potential role in combating malnu-
trition and hunger, the introduction of genet-
ically modified (GM) foods has been strongly 
contested since their commercialization in 1996. 
Attitudes toward GM foods have been influ-
enced by whether they confer value to producers 
or consumers. While the introduction of first 
generation GM foods that conferred agronomic 
benefits to producers was initially met with 
strong consumer opposition (Giannakas and 
Yiannaka 2008), second generation, consumer-
oriented GM products, which have enhanced  
_____________ 
1 The three laureates who developed the orange fleshed 
sweet potato are Drs. Maria Andrade, Jan Low and Robert 
Mwanga, all with the International Potato Center. Dr. 
Howarth Bouis, the fourth laureate is the founder of Har-
vestPlus at the International Food Policy Research Insti-
tute (IFPRI).  
Market Report  Year 
Ago  4 Wks Ago  10-28-16 
Livestock and Products, 
Weekly Average          
Nebraska Slaughter Steers, 
35-65% Choice, Live Weight. . . . . . .  138.14  100.21  104.04 
Nebraska Feeder Steers, 
Med. & Large Frame, 550-600 lb. . . . .  220.29  143.09  133.80 
Nebraska Feeder Steers, 
Med. & Large Frame 750-800 lb. . .. .  200.83  141.27  138.71 
Choice Boxed Beef, 
600-750 lb. Carcass. . . . . . . . . . . . . .  219.22  186.63  182.00 
Western Corn Belt Base Hog Price 
Carcass, Negotiated . . . . . . . . . . . . . ..  60.77  48.53  44.87 
Pork Carcass Cutout, 185 lb. Carcass 
51-52% Lean. . . . . . . . . . . . . . . . . . . .  81.94  75.24  72.64 
Slaughter Lambs, wooled and shorn, 
135-165 lb. National. . . . . . .  156.73  158.36  146.03 
National Carcass Lamb Cutout 
FOB. . . . . . . . . . . . . . . . . . . . . . . . . . .  357.69  353.14  351.19 
Crops, 
Daily Spot Prices          
Wheat, No. 1, H.W. 
Imperial, bu. . . . . . . . . . . . . . . . . . . . .  4.14  2.64  2.74 
Corn, No. 2, Yellow 
Nebraska City, bu. . . . . . . . . . . . . . . .  3.52  NA  NA 
Soybeans, No. 1, Yellow 
Nebraska City, bu. . . . . . . . . . . . . .. . .  8.26  NA  NA 
Grain Sorghum, No.2, Yellow 
Dorchester, cwt. . . . . . . . . . . . . . . . . .  5.93  4.66  4.82 
Oats, No. 2, Heavy 
Minneapolis, Mn, bu. . . . . . . . . . . . . . .  2.60  2.51  2.78 
Feed          
Alfalfa, Large Square Bales, 
Good to Premium, RFV 160-185 
Northeast Nebraska, ton. . . . . . . . . . .  185.00  160.00  160.00 
Alfalfa, Large Rounds, Good 
Platte Valley, ton. . . . . . . . . . . . . . . . .  75.00  68.75  67.50 
Grass Hay, Large Rounds, Good 
 Nebraska, ton. . . . . . . . . . . . . . .. . . .  77.50  70.00  67.50 
Dried Distillers Grains, 10% Moisture 
Nebraska Average. . . . . . . . . . . . . . . .  112.50  112.50  108.00 
Wet Distillers Grains, 65-70% Moisture 
Nebraska Average. . . . . . . . . . . . . . . .  49.50  40.50  41.75 
 ⃰ No Market          
functional properties (e.g., bio-fortified GM foods), 
have been gaining acceptance by consumers (De Steur 
et al. 2015). Building on second generation GM foods, 
recently developed third generation GM food products 
claim to provide health and disease treatment benefits 
to consumers. Nutraceuticals, as such products are are 
called, are foods or parts of foods that provide medici-
nal or health benefits to consumers, including the pre-
vention and treatment of diseases (Kalra 2003). Genet-
ically engineered (GE) nutraceuticals thus include 
foods associated with increased health benefits and/or 
disease prevention (second generation GM food prod-
ucts), but also plants and animal products that could 
be used to create vaccines and drugs to treat or cure 
diseases (third generation GM products). Examples of 
GE nutraceuticals are rice that can be used for a chol-
era vaccine (Murnaghan 2012), GE bananas that can be 
used for a Hepatitis B vaccine (American Chemical 
Society 2007), and a GE version of the tobacco plant 
that could be used in a vaccine for the human papillo-
mavirus (HPV) or cervical cancer. At present, Astellas 
Pharma in Japan is at the forefront of conducting clini-
cal trials for a vaccine in rice against diarrheal diseases 
such as cholera (Taylor 2016).  
In the United States, the Food and Drug Administra-
tion (FDA) regulates nutraceuticals either as a dietary 
supplement or a food ingredient depending on how 
they are marketed by manufacturers (FDA 2016). The 
market for nutraceuticals is growing with an expand-
ing global market valued at $165 billion in 2014 and 
projected to attain a staggering $278 billion by 2021 
(Transparency Market Research 2016). 
A study conducted by researchers in the Department 
of Agricultural Economics at the University of Nebras-
ka-Lincoln (UNL) examined public attitudes and pur-
chase intentions for GE nutraceuticals that either offer 
general health benefits or a treatment/cure for diseases. 
The study also examined how GE nutraceuticals are 
perceived with respect to their conventional and or-
ganic counterparts. An online survey that elicited re-
sponses related to views on GMOs, attitudes towards 
food labeling, preferences for genetically engineered 
nutraceuticals and demographic information was com-
pleted by 1,271 randomly selected students at UNL.  
Survey results show that although the majority of re-
spondents view GM food products favorably, they nev-
ertheless express a strong preference for GM labeling. 
Faced with a choice between a GE nutraceutical with a 
disease treatment benefit and an organic food sub-
stitute with no such benefits, both sold at the same 
price, nearly half of all respondents indicated they 
would choose the GE nutraceutical, a quarter were 
indifferent between the two, while a quarter of re-
spondents indicated a preference for the organic 
food product. When asked to consider a choice 
between a GE nutraceutical that offers general 
health benefits and its organic counterpart, both 
sold at the same price, respondents were evenly 
split with a third preferring the GE nutraceutical 
that offered general health benefits, a third were 
indifferent between the two, while the remainder 
one third preferred the organic food product.  
In terms of purchase intentions, over 60% of re-
spondents were equally willing to purchase GE 
nutraceuticals that offered treatment for diseases, 
versus GE nutraceuticals that offered general 
health benefits, such as disease prevention. A little 
more than a quarter of respondents were, howev-
er, more willing to purchase the GE nutraceuticals 
with the disease treatment benefit and were willing 
to pay an average price premium of 20% more for 
such products. Overall, the majority of respond-
ents expressed willingness to purchase GE 
nutraceuticals developed to treat an illness, im-
prove health and prevent diseases, as shown in 
Figure 1. However, price appeared to be a key de-
terminant—less than a fifth of respondents would 
likely purchase GE nutraceuticals if they were 
more expensive than their conventional counter-
parts.  
Figure 1. Purchase intention for GE nutraceuticals 
with different functionalities 
 
Two methodological approaches were used to analyze 
the data. The multinomial logistic regression was used 
to analyze unordered dependent variables pertaining to 
preferences between GE nutraceuticals that offer gen-
eral health benefits and treatment for diseases versus 
an organic food substitute that does not offer the same 
benefits. A tobit model was used to analyze factors that 
influenced respondents’ willingness to pay a premium 
for GE nutraceuticals that offered treatment for diseas-
es versus one that offered general health benefits, such 
as disease prevention. Empirical findings reveal that a 
number of respondent characteristics influence their 
preference for GE nutraceuticals. Specifically, respond-
ents who paid greater attention to food production 
processes were 1.14 times less likely to purchase GE 
nutraceuticals that offered general health benefits, and 
instead had a 47% increase in their odds of purchasing 
an organic food product, relative to being indifferent 
between the two products. As expected, acceptance of 
the use of genetic modification in food production was 
associated with a greater acceptance of GE nutraceuti-
cals. The partial odds of this group purchasing GE 
nutraceuticals that offered general health benefits and 
treatment against diseases increased by a factor of 1.98 
and 1.65 times, respectively. Study results also indicate 
price sensitivity among respondents, including those 
more accepting of GM foods; not a surprising result 
given that our sample consists of college students. In 
light of the growing acceptance of bio-fortified GM 
foods, the above result suggests that GE nutraceuticals 
could further increase consumer acceptance and the 
market potential of GM foods. 
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